JBPOS0101 Uses, Dosage, Side Effects and more
JBPOS0101 is under investigation in clinical trial NCT03976076 (A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients).
| Trade Name | JBPOS0101 |
| Generic | JBPOS0101 |
| Type | |
| Formula | C10H12ClNO3 |
| Weight | Average: 229.66 Monoisotopic: 229.050571 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
